Ventavis
information and resources from the National Cancer Institute
Ventavis
(Other name for: iloprost)VePesid
(Other name for: etoposide)Ventavis
(Other name for: iloprost)
|
|
|
|
news articles
CoTherix launches trial of Ventavis in combination with sildenafil ... Mar 30, 2006
Therapeutics Daily (subscription) (press release), CoTherix, Inc., (CTRX) announced the initiation of a phase III trial of Ventavis (iloprost) Inhalation Solution in combination with sildenafil citrate. ...
CoTherix Initiates Trial of Ventavis in Combination With ... Mar 8, 2006
PR Newswire (press release), ...(Nasdaq: CTRX) today announced the initiation of a Phase III trial of Ventavis(R) (iloprost) Inhalation Solution in combination with sildenafil citrate. ...
Myogen helped by Thelin delay? Mar 28, 2006
Monsters and Critics.com, In addition to Actelion, the big players in this market are Pfizer`s Revatio, United Therapeutics` Remodulin, GlaxoSmithKline`s Flolan and CoTherix`s Ventavis. ...
CoTherix, Inc. Reports Fourth Quarter and Year End 2005 Results Mar 8, 2006
Yahoo! News (press release) Net product sales from the company's Ventavis® Inhalation Solution in the fourth quarter of 2005 were $11.0 million, up 30 percent from $8.4 million in the ...
CoTherix to Webcast Presentations From Two Upcoming Investor ... Mar 23, 2006
Yahoo! News (press release) CoTherix's Ventavis® (iloprost) Inhalation Solution was approved by the FDA in December 2004 for the treatment of pulmonary arterial hypertension (PAH) in ...
CoTherix Initiates Combination Trial of PAH Drug Mar 9, 2006
International News Service, CoTherix has initiated a phase III trial of Ventavis inhalation solution in combination with sildenafil citrate for the treatment of pulmonary arterial ...
CoTherix narrows 4Q loss Mar 8, 2006
BusinessWeek ...million. Sales of the drug Ventavis totaled about $11 million for the quarter and $23.9 million since it's launch in March 2005. ...
PAH: market ripe for expansion as big pharma interest increases Mar 27, 2006
Pharmaceutical Business Review ...sparked by the launch of three new therapies and formulations in the US - United Therapeutics' IV Remodulin (treprostinil), CoTherix' Ventavis (iloprost), and ...
Encysive Shares Tumble On FDA Thelin Approvable Letter Mar 27, 2006
BioWorld Online (subscription), ...therapies for the condition include the prostacyclins Remodulin (treprostinil sodium, from United Therapeutics Corp.) and the inhaled Ventavis (iloprost, from ...
CoTherix and Respironics Announce Launch of New Portable ... Dec 13, 2005
Yahoo! News (press release) ...(Nasdaq: RESP - News) announced today the launch of a new portable, battery-operated inhalation device for the delivery of Ventavis® (iloprost) Inhalation ...
CoTherix and Respironics Announce Launch of New Portable ... Dec 13, 2005
PharmaLive.com (press release), ...announced today the launch of a new portable, battery-operated inhalation device for the delivery of Ventavis(R) (iloprost) Inhalation Solution. ...
Competition looms for Silver Spring drugmaker Dec 13, 2005
Business Gazette, He said physicians are telling him that an inhaled treatment for pulmonary arterial hypertension called Ventavis, made by CoTherix Inc. ...
CoTherix initiated with "buy" - update Dec 7, 2005
New Ratings In a research note published yesterday, the analysts mention that the company’s lead product, Ventavis, is expected to become the prostacyclin standard-of ...
A Rothschild Pigeon for Health Care Investors Dec 16, 2005
New York Sun, ...$12).The company has recently launched, in partnership with Respironics (RESP $38), a portable inhalation device to deliver the drug Ventavis, prescribed for ...
Zacks Industry Outlook Highlights: Bio-Rad Labs, Gilead Sciences ... Dec 1, 2005
Business Wire (press release), The company's Ventavis(R) (iloprost) Inhalation Solution watched net product sales more than double to $8.4 million. Furthermore ...
(PRN) - Brookstone Announces Third Quarter 2005 Financial Results ... Dec 13, 2005
Bolsamania.com, Gel ... [+. PRN) - CoTherix and Respironics Announce Launch of New Portable Inhalation Device to Ventavis Patients ... [+. PRN ...
|
|
